» Articles » PMID: 39200101

The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens

Overview
Journal Biomedicines
Date 2024 Aug 29
PMID 39200101
Authors
Affiliations
Soon will be listed here.
Abstract

The role of estrogens in prostate cancer (PCa) is shrouded in mystery, with its actions going from angelic to devilish. The findings by Huggins and Hodges establishing PCa as a hormone-sensitive cancer have provided the basis for using estrogens in therapy. However, despite the clinical efficacy in suppressing tumor growth and the panoply of experimental evidence describing its anticarcinogenic effects, estrogens were abolished from PCa treatment because of the adverse secondary effects. Notwithstanding, research work over the years has continued investigating the effects of estrogens, reporting their pros and cons in prostate carcinogenesis. In contrast with the beneficial therapeutic effects, many reports have implicated estrogens in the disruption of prostate cell fate and tissue homeostasis. On the other hand, epidemiological data demonstrating the lower incidence of PCa in Eastern countries associated with a higher consumption of phytoestrogens support the beneficial role of estrogens in counteracting cancer development. Many studies have investigated the effects of phytoestrogens and the underlying mechanisms of action, which may contribute to developing safe estrogen-based anti-PCa therapies. This review compiles the existing data on the anti- and protumorigenic actions of estrogens and summarizes the anticancer effects of several phytoestrogens, highlighting their promising features in PCa treatment.

Citing Articles

Downregulated Regucalcin Expression Induces a Cancer-like Phenotype in Non-Neoplastic Prostate Cells and Augments the Aggressiveness of Prostate Cancer Cells: Interplay with the G Protein-Coupled Oestrogen Receptor?.

Fonseca L, Carreira R, Feijo M, Cavaco J, Cardoso H, Vaz C Cancers (Basel). 2024; 16(23).

PMID: 39682121 PMC: 11640704. DOI: 10.3390/cancers16233932.


Effect of Diosgenin in Suppressing Viability and Promoting Apoptosis of Human Prostate Cancer Cells: An Interplay with the G Protein-Coupled Oestrogen Receptor?.

Figueira M, Marques R, Cardoso H, Fonseca L, Duarte A, Silvestre S Int J Mol Sci. 2024; 25(22).

PMID: 39596074 PMC: 11593390. DOI: 10.3390/ijms252212006.

References
1.
Banerjee P, Banerjee S, Brown T, Zirkin B . Androgen action in prostate function and disease. Am J Clin Exp Urol. 2018; 6(2):62-77. PMC: 5902724. View

2.
Medjakovic S, Jungbauer A . Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor. J Steroid Biochem Mol Biol. 2007; 108(1-2):171-7. DOI: 10.1016/j.jsbmb.2007.10.001. View

3.
Tsai P, Cheng C, Lin C, Huang Y, Lee L, Kandaswami C . Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells. Anticancer Res. 2016; 36(12):6367-6380. DOI: 10.21873/anticanres.11234. View

4.
Djerassi C, Rosenkranz G, Pataki J, Kaufmann S . Steroids, XXVII. Synthesis of allopregnane-3beta, 11beta, 17alpha-, 20beta, 21-pentol from cortisone and diosgenin. J Biol Chem. 1952; 194(1):115-8. View

5.
Zhu Y, Wu J, Li S, Wang X, Liang Z, Xu X . Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer. Mol Med Rep. 2014; 11(2):1004-8. DOI: 10.3892/mmr.2014.2801. View